График акции Eledon Pharmaceuticals, Inc.
Расширенный график
Простой график
О компании
Eledon Pharmaceuticals, Inc. operates as a clinical stage biotechnology company. The company uses its immunology expertise in targeting the CD40 Ligand (CD40L, also called CD154) pathway to develop therapies to protect transplanted organs and prevent rejection, and to treat amyotrophic lateral sclerosis (ALS). The company's lead compound in development is tegoprubart, an anti-CD40L antibody with high affinity for CD40 Ligand, a biological target with therapeutic potential. It has a collaboration agreement with eGenesis, Inc. The company was formerly known as Novus Therapeutics, Inc. подробнее| IPO date | 2014-09-17 |
|---|---|
| ISIN | US28617K1016 |
| Industry | Biotechnology |
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | usd |
| Сайт | https://eledon.com |
| Цена ао | 2.12 |
| Изменение цены за день: | -0.4577% (4.37) |
|---|---|
| Изменение цены за неделю: | -0.2294% (4.36) |
| Изменение цены за месяц: | +2.11% (4.26) |
| Изменение цены за 3 месяца: | +74.7% (2.49) |
| Изменение цены за полгода: | +80.5% (2.41) |
| Изменение цены за год: | +141.67% (1.8) |
| Изменение цены за 3 года: | -3.12% (4.49) |
| Изменение цены за 5 лет: | +623.79% (0.601) |
| Изменение цены за 10 лет: | 0% (4.35) |
| Изменение цены с начала года: | -6.95% (4.675) |
|
|
Недооценка
|
Эффективность
|
|||||||||||||||||||||||||||||||||||||
Дивиденды
|
Долг
|
Импульс роста
|
|||||||||||||||||||||||||||||||||||||
| Институционалы | Объем | Доля, % |
|---|---|---|
| BVF Inc. | 4326710 | 17.88 |
| Armistice Capital, LLC | 1824000 | 7.54 |
| Vanguard Group Inc | 674520 | 2.79 |
| Woodline Partners LP | 603993 | 2.5 |
| Ensign Peak Advisors, Inc | 443001 | 1.83 |
| CM Management, LLC | 234803 | 0.97 |
| Geode Capital Management, LLC | 176039 | 0.73 |
| Royal Bank of Canada | 158207 | 0.65 |
| Renaissance Technologies, LLC | 61973 | 0.26 |
| JMAC Enterprises LLC | 58041 | 0.24 |
| ETF | Доля, % | Доходность за год, % | Дивиденды, % |
|---|---|---|---|
| iShares Micro-Cap ETF | 0.02284 | 17.09 | 1.54048 |
| Dimensional U.S. Targeted Value ETF | 0.00028 | 26.01 | 1.93487 |
| Dimensional U.S. Core Equity 2 ETF | 0.00015 | 30.76 | 1.47098 |
| Руководитель | Должность | Оплата | Год рождения |
|---|---|---|---|
| Dr. David-Alexandre C. Gros M.D., Ph.D. | CEO & Non Independent Director | 807.96k | 1972 (53 года) |
| Dr. Steven N. Perrin Ph.D. | President, Chief Scientific Officer & Non Independent Director | 603.9k | 1966 (59 лет) |
| Mr. Paul Sean Little | Chief Financial Officer | 611.71k | 1965 (60 лет) |
| Mr. John Herberger | Vice President of Technical Operations | N/A | |
| Mr. Bryan E. Smith J.D. | General Counsel, Corporate Secretary & Chief Compliance Officer | 377.14k | 1980 (45 лет) |
| Dr. David Hovland Ph.D. | Chief Regulatory Officer | N/A | |
| Dr. Eliezer Katz F.A.C.S., FACS, M.D. | Chief Medical Officer | N/A |
Адрес: United States, Irvine. CA, 19900 MacArthur Boulevard - открыть в Google картах, открыть Яндекс картах
Сайт: https://eledon.com
Сайт: https://eledon.com
